TREATMENT OPTIMIZATION AFTER ND: YAG CAPSULOTOMY USING COMBINATION THERAPY

Nd:YAG laser capsulotomy remains the most common treatment for secondary cataract, performed on millions of patients worldwide each year. Although effective, the procedure can be accompanied by complications such as transient ophthalmic hypertension, inflammation, and cystic macular edema, which reduce visual outcome. With the growing elderly population and the expansion of outpatient care, standardization of medication management after capsulotomy is particularly relevant. The lack of uniform protocols, variability of approaches, and the emergence of new drugs, including rock inhibitors, emphasize the need to develop personalized treatment regimens based on evidence-based medicine.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-06-02
DOI
https://doi.org/10.5281/zenodo.15575160
Primary Topic
Intraocular Surgery and Lenses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TREATMENT OPTIMIZATION AFTER ND: YAG CAPSULOTOMY USING COMBINATION THERAPY

Zenodo (CERN European Organization for Nuclear Research)
Intraocular Surgery and Lenses
article

TREATMENT OPTIMIZATION AFTER ND: YAG CAPSULOTOMY USING COMBINATION THERAPY

article en

Abstract

Nd:YAG laser capsulotomy remains the most common treatment for secondary cataract, performed on millions of patients worldwide each year. Although effective, the procedure can be accompanied by complications such as transient ophthalmic hypertension, inflammation, and cystic macular edema, which reduce visual outcome. With the growing elderly population and the expansion of outpatient care, standardization of medication management after capsulotomy is particularly relevant. The lack of uniform protocols, variability of approaches, and the emergence of new drugs, including rock inhibitors, emphasize the need to develop personalized treatment regimens based on evidence-based medicine.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 39%
Intraocular Surgery and Lenses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

TREATMENT OPTIMIZATION AFTER ND: YAG CAPSULOTOMY USING COMBINATION THERAPY · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS